Chang‐Woo Yeo

661 total citations
23 papers, 536 citations indexed

About

Chang‐Woo Yeo is a scholar working on Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chang‐Woo Yeo has authored 23 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Oncology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chang‐Woo Yeo's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (10 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Chang‐Woo Yeo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (10 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Chang‐Woo Yeo collaborates with scholars based in South Korea, China and United States. Chang‐Woo Yeo's co-authors include Jae‐Gook Shin, Ji‐Hong Shon, Im‐Sook Song, Ho Jung Shin, Sang Seop Lee, Doo‐Yeoun Cho, Su‐Jun Lee, Kwang‐Hyeon Liu, Soo Kyung Bae and Ho-Sook Kim and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Chang‐Woo Yeo

23 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chang‐Woo Yeo South Korea	14	245	200	83	82	76	23	536
Tuija Tapaninen Finland	13	246 1.0×	275 1.4×	88 1.1×	79 1.0×	91 1.2×	20	582
Mikael S. Thomsen Denmark	14	304 1.2×	172 0.9×	67 0.8×	47 0.6×	129 1.7×	25	751
In‐Jin Jang South Korea	14	222 0.9×	153 0.8×	146 1.8×	70 0.9×	105 1.4×	27	660
Andrea Soldner United States	9	200 0.8×	219 1.1×	78 0.9×	110 1.3×	178 2.3×	10	681
Rahul Shah United States	14	309 1.3×	169 0.8×	78 0.9×	138 1.7×	156 2.1×	36	785
Yacoub M. Irshaid Jordan	13	263 1.1×	139 0.7×	82 1.0×	61 0.7×	163 2.1×	48	697
Pil‐Whan Park South Korea	11	232 0.9×	144 0.7×	39 0.5×	57 0.7×	44 0.6×	17	425
Jianghua Tu China	13	243 1.0×	197 1.0×	54 0.7×	52 0.6×	167 2.2×	17	582
Quan Zhou China	13	189 0.8×	105 0.5×	73 0.9×	57 0.7×	104 1.4×	59	477
R Temple United States	4	261 1.1×	192 1.0×	64 0.8×	34 0.4×	113 1.5×	5	554

Countries citing papers authored by Chang‐Woo Yeo

Since Specialization

Citations

This map shows the geographic impact of Chang‐Woo Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Woo Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Woo Yeo more than expected).

Fields of papers citing papers by Chang‐Woo Yeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Woo Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Woo Yeo. The network helps show where Chang‐Woo Yeo may publish in the future.

Co-authorship network of co-authors of Chang‐Woo Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Woo Yeo. A scholar is included among the top collaborators of Chang‐Woo Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Woo Yeo. Chang‐Woo Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oh, Minkyung, Chang‐Woo Yeo, Ho-Sook Kim, Ji‐Hong Shon, & Jae‐Gook Shin. (2018). Genotype-based enrichment study design for minimizing the sample size in bioequivalence studies using tolterodine and CYP2D6 genotype. International Journal of Clinical Pharmacology and Therapeutics. 57(2). 110–116. 1 indexed citations

Park, Soo‐Jin, Chang‐Woo Yeo, Eon‐Jeong Shim, et al.. (2015). Pomegranate juice does not affect the disposition of simvastatin in healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics. 41(4). 339–344. 12 indexed citations

Jiang, Fen, Chang‐Woo Yeo, Minkyung Oh, et al.. (2013). Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals. Pharmacogenetics and Genomics. 23(3). 175–179. 5 indexed citations

Shinde, Dhananjay, Soo Kyung Bae, Chang‐Woo Yeo, et al.. (2013). Different Effects of Clopidogrel and Clarithromycin on the Enantioselective Pharmacokinetics of Sibutramine and its Active Metabolites in Healthy Subjects. The Journal of Clinical Pharmacology. 53(5). 550–558. 5 indexed citations

Lee, Ji Won, Hyoung Jin Kang, Ji‐Yeob Choi, et al.. (2013). Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent. PLoS ONE. 8(5). e64114–e64114. 23 indexed citations

Yeo, Chang‐Woo, Minkyung Oh, Jong‐Lyul Ghim, et al.. (2013). The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. British Journal of Clinical Pharmacology. 77(5). 821–830. 16 indexed citations

Jiang, Fen, Zeruesenay Desta, Ji‐Hong Shon, et al.. (2012). Effects of clopidogrel and itraconazole on the disposition of efavirenz and its hydroxyl metabolites: exploration of a novel CYP2B6 phenotyping index. British Journal of Clinical Pharmacology. 75(1). 244–253. 22 indexed citations

Bae, Soo‐Kyung, Eon‐Jeong Shim, Soo‐Jin Park, et al.. (2012). Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism. Xenobiotica. 43(2). 211–218. 5 indexed citations

Lee, Su‐Jun, Eunji Jung, Chang‐Woo Yeo, et al.. (2011). Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregation. Thrombosis Research. 127(3). 220–227. 20 indexed citations

10.

Yeo, Chang‐Woo, Su‐Jun Lee, Sang Seop Lee, et al.. (2011). Discovery of a Novel Allelic Variant of CYP2C8, CYP2C8*11, in Asian Populations and Its Clinical Effect on the Rosiglitazone Disposition In Vivo. Drug Metabolism and Disposition. 39(4). 711–716. 19 indexed citations

11.

Cho, Hoon, Min‐Koo Choi, Chang‐Woo Yeo, et al.. (2011). Effect of CYP2C19 Genetic Polymorphism on Pharmacokinetics and Pharmacodynamics and Pharmacodynamics of a New Proton Pump Inhibitor, Ilaprazole. The Journal of Clinical Pharmacology. 52(7). 976–984. 37 indexed citations

12.

Kim, Eun Young, et al.. (2010). Robust CYP2D6 genotype assay including copy number variation using multiplex single-base extension for Asian populations. Clinica Chimica Acta. 411(23-24). 2043–2048. 20 indexed citations

13.

Lee, Dong Jun, et al.. (2009). Simultaneous quantification of rosiglitazone and its two major metabolites, N-desmethyl and p-hydroxy rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry: Application to a pharmacokinetic study. Journal of Chromatography B. 877(20-21). 1951–1956. 10 indexed citations

14.

Lee, Su‐Jun, Sang Seop Lee, Ho-Sook Kim, et al.. (2009). Discovery of Novel Functional Variants and Extensive Evaluation of CYP2D6 Genetic Polymorphisms in Koreans. Drug Metabolism and Disposition. 37(7). 1464–1470. 59 indexed citations

15.

Shon, Ji‐Hong, et al.. (2009). Itraconazole and Rifampin Alter Significantly the Disposition and Antihistamine Effect of Ebastine and Its Metabolites in Healthy Participants. The Journal of Clinical Pharmacology. 50(2). 195–204. 12 indexed citations

16.

Bae, Soo Kyung, et al.. (2008). Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography–tandem mass spectrometry: application to pharmacokinetic study of Astrix^® in Korean healthy volunteers. Biomedical Chromatography. 22(6). 590–595. 44 indexed citations

17.

Bae, Soo Kyung, Chang‐Woo Yeo, Min‐Jung Kim, et al.. (2008). Simultaneous determination of udenafil and its active metabolite, DA‐8164, in human plasma and urine using ultra‐performance liquid chromatography–tandem mass spectrometry: application to a pharmacokinetic study. Biomedical Chromatography. 22(9). 939–946. 13 indexed citations

18.

Shon, Ji‐Hong, Ho Jung Shin, Soo‐Jin Park, et al.. (2008). Effect of Silymarin Supplement on the Pharmacokinetics of Rosuvastatin. Pharmaceutical Research. 25(8). 1807–1814. 48 indexed citations

19.

Lee, Sang Seop, Hyun‐Ju Jung, Ji‐Hong Shon, et al.. (2008). Genetic polymorphism of hepatocyte nuclear factor‐4α influences human cytochrome P450 2D6 activity†. Hepatology. 48(2). 635–645. 22 indexed citations

20.

Song, Im‐Sook, Ho Jung Shin, Chang‐Woo Yeo, et al.. (2008). The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15. Pharmacogenetics and Genomics. 18(5). 424–433. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact